Vericel Corp (VCEL)

• Market cap: $2.92B
• 1 day: 4.83%
• 5 days: 0.34%
• 1 month: 4.20%
• 3 months: 45.24%
• 6 months: 14.21%
• Year to date: 7.19%
• 1 year: 56.15%
• 5 years: 238.12%
• 10 years: 2,146.01%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

368% more call options, than puts

Call options by funds: $4.67M | Put options by funds: $997K

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

12% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 89

2% more funds holding

Funds holding: 257 [Q2] → 263 (+6) [Q3]

0.64% less ownership

Funds ownership: 106.05% [Q2] → 105.4% (-0.64%) [Q3]

8% less capital invested

Capital invested by funds: $2.36B [Q2] → $2.17B (-$198M) [Q3]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q2] → 1 (-1) [Q3]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $60 2% upside
• Avg. target: $64 8% upside
• High target: $67 13% upside

5 analyst ratings

• positive: 5 100%
• neutral: 0 0%
• negative: 0 0%

Stephens & Co. Mason Carrico 68% 1-year accuracy 13 / 19 met price target	10% upside $65	Overweight Reiterated	15 Jan 2025
HC Wainwright & Co. Swayampakula Ramakanth 34% 1-year accuracy 63 / 188 met price target	2% upside $60	Buy Reiterated	15 Jan 2025
Truist Securities Samuel Brodovsky 85% 1-year accuracy 11 / 13 met price target	13% upside $67	Buy Maintained	18 Dec 2024
BTIG Ryan Zimmerman 68% 1-year accuracy 32 / 47 met price target	12% upside $66	Buy Maintained	26 Nov 2024
Canaccord Genuity Caitlin Cronin 67% 1-year accuracy 8 / 12 met price target	2% upside $60	Buy Maintained	19 Nov 2024